7/21/2023NHSA Issues the Rules for Contract Renewal of Negotiated Drugs and the...

7/21/2023Recent Executive Moves

7/20/2023Biotheus Enters Strategic Research and License Pact with BioNTech

7/20/2023Sanofi Remains Bullish on China's Prospects with Plans to Launch More ...

7/19/2023NHC Issues the Guiding Opinions for Advancing Clinical Specialty Capac...

7/19/2023Chinese Hospital Drug Market Rebounded Sharply in Q1/2023: Sinohealth

7/17/2023WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturin...

7/17/2023NMPA Announces Additional Professional Journal Approved for Rx Drug Ad...

7/17/2023NMPA Solicits Comments on the Technical Guidelines for Clinical Resear...

7/17/2023China's Pharma Financing Slump Continued in H1 (PharmaDJ)

7/14/2023Bayer to Launch More Innovative Drugs in China

7/14/2023Review of Chinese Retail Pharmacy Sales 2013-2022

7/14/2023Snapshot of Import Drugs Approved by NMPA in 2022 (2)

7/14/2023PhIIC: Review of Chinese Hospital Drug Market in Q1/2023

7/14/2023Recent Executive Moves

7/12/2023BeiGene Announces FDA Acceptance of sNDA for Fifth BRUKINSA Indication

7/12/2023LianBio Announces Clinical Supply Agreement with AZ China to Evaluate ...

7/12/2023China Issues Notice to Strengthen Essential Public Health Services in ...

7/12/2023GeneQuantum and Aimed Bio to Co-develop Five Innovative ADC Drugs

7/11/2023Novartis Returns $300M Candidate to BeiGene as It Retreats from TIGIT ...

7/10/2023WuXi Biologics Announces Proposed Spin-off and Separate Listing of WuX...

7/10/2023Tapping New and Improved Drug Innovations in Asia (PharmExec)

7/7/2023NHC Establishes National-level Medical Emergency Response Expert Group

7/7/2023Recent Executive Moves

7/6/2023Sirnaomics Establishes a Strategic Partnership with RNA-Editing Firm E...

7/6/2023Takeda and Sino Biopharma's Five Star Join Hands to Develop New Genera...

7/5/2023Moderna Set to Make First Investment of $1B in China: Sources

7/5/2023NMPA and Chinese Customs Announce the Customs Commodity Codes of Oxeli...

7/5/2023Biocytogen and Pheon Enter Antibody License Pact

7/5/2023China Offers An Olive Branch to Frustrated MNC Pharma Firms: Reuters

Page:43/355 Total number of articles:10627: [First][<<] [41] [42] [43] [44] [45] [>>] [End]